Azamian Bobak R.

CIK 00018276721 companyIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001827672

Recent Transactions

50 trades

Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-09-02$80.06/sh−10,000→ 837,991 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-06-17$61.24/sh−4,582→ 853,409 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-06-17$61.81/sh−5,418→ 847,991 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-19$67.00/sh−11,964→ 33,421 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-18$68.71/sh−11,667→ 45,385 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-17$69.42/sh−10,972→ 57,052 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-15−11,300→ 0 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-15+66,274→ 68,024 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-15−16,975→ 16,975 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-15−14,878→ 44,634 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-15−23,121→ 46,243 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-05+60,776→ 60,776 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-03-05+96,723→ 96,723 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-24$82.41/sh−5,443→ 858,548 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-24$83.54/sh−557→ 857,991 total
Gift
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-04−51,885→ 1,750 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-09-24$55.37/sh−6,000→ 812,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-08-11$50.00/sh−6,000→ 818,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-24$50.00/sh−6,000→ 824,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-20$50.11/sh−8,534→ 53,635 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-19$47.40/sh−8,551→ 62,169 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-18$46.29/sh−7,131→ 70,720 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−23,121→ 69,364 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-15+51,395→ 77,851 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−11,299→ 11,300 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−16,975→ 33,950 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-03-05+90,736→ 90,736 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-05+59,512→ 59,512 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-18$30.60/sh−10,415→ 26,456 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-15+28,274→ 36,871 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−16,975→ 50,925 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−11,299→ 22,599 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-03-07+136,947→ 136,947 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-07+92,485→ 92,485 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-12-27$20.22/sh−8,000→ 830,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-12-20$19.96/sh−9,443→ 868,663 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-12-20$20.36/sh−30,557→ 838,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-11-15$18.01/sh−2,896→ 883,210 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-11-15$18.54/sh−4,904→ 878,306 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-11-15$19.28/sh−200→ 878,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-10-18$13.24/sh−8,000→ 886,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-09-20$17.21/sh−8,000→ 894,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-08-23$17.23/sh−8,000→ 902,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-07-19$20.04/sh−99,726→ 910,106 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-07-19$19.28/sh−4,174→ 1,009,832 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-07-12$17.35/sh−9,000→ 1,014,006 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-21$18.63/sh−8,000→ 1,023,006 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-14$18.58/sh−9,000→ 1,031,006 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-08$20.01/sh−3,100→ 1,040,006 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-05-17$15.90/sh−8,000→ 1,043,106 total

Companies

Tarsus Pharmaceuticals, Inc.
Director, President/CEO and Board Chair
$TARS

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618

View on SEC.gov